by ATA Action | May 9, 2023 | Press Releases
WASHINGTON, DC, MAY 9, 2023 – The American Telemedicine Association (ATA) and ATA Action issued the following statement in response to the Drug Enforcement Administration’s (DEA) and Substance Abuse and Mental Health Services Administration’s (SAMHSA) temporary...
by Alexis apple | May 4, 2023 | Press Releases
WASHINGTON, DC, MAY 4, 2023 – The American Telemedicine Association (ATA) and ATA Action issued the following statement in response to the Drug Enforcement Administration’s (DEA) extension of COVID-19 telemedicine flexibilities for the remote prescription of...
by ATA Action | Mar 30, 2023 | Press Releases
WASHINGTON, DC, MARCH 29, 2023 – ATA Action officially submitted comprehensive comments regarding the Drug Enforcement Administration (DEA)’s proposed rules regarding the remote prescribing of controlled substances. In two letters to the DEA, ATA Action outlined...
by Alexis apple | Jan 4, 2023 | Press Releases
ATA and ATA ACTION Applaud Congress and the Administration, Renew Commitment to Seeking Permanency for Telehealth Services WASHINGTON, DC, JANUARY 3, 2023 – The American Telemedicine Association (ATA) and ATA Action issued the following statement, following...
by Alexis apple | Dec 23, 2022 | Press Releases
WASHINGTON, DC, DECEMBER 23, 2022 – Following a historic vote in Congress today, the American Telemedicine Association (ATA) and ATA Action issued the following statement expressing appreciation to the numerous Congressional telehealth champions who believe in the...
by Alexis apple | Dec 20, 2022 | Press Releases
WASHINGTON, DC, DECEMBER 20, 2022 – Today, the American Telemedicine Association (ATA) and ATA Action express their gratitude to the U.S. Congress for unveiling a bipartisan, bicameral omnibus appropriations bill that includes a two-year extension for Medicare...